ACH
DTIL icon

ArrowMark Colorado Holdings’s Precision BioSciences DTIL Stock Holding History

ArrowMark Colorado Holdings’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$985K Buy
+179,140
New +$826K 0.03% 247
2024
Q1 		– Sell
-3,163
Closed -$34.6K – 323
2023
Q4 		$34.6K Sell
3,163
-148
-4% -$1.6K ﹤0.01% 305
2023
Q3 		$33.9K Hold
3,311
– – ﹤0.01% 305
2023
Q2 		$52.2K Sell
3,311
-9,417
-74% -$215K ﹤0.01% 299
2023
Q1 		$288K Sell
12,728
-2,618
-17% -$86.3K ﹤0.01% 287
2022
Q4 		$548K Hold
15,346
– – 0.01% 266
2022
Q3 		$598K Sell
15,346
-17
-0.1% -$808 0.01% 284
2022
Q2 		$737K Sell
15,363
-3,598
-19% -$211K 0.01% 278
2022
Q1 		$1.75M Sell
18,961
-41,520
-69% -$5.64M 0.02% 272
2021
Q4 		$13.4M Sell
60,481
-14,223
-19% -$3.97M 0.11% 159
2021
Q3 		$25.9M Sell
74,704
-4,151
-5% -$1.41M 0.2% 116
2021
Q2 		$27.6M Sell
78,855
-914
-1% -$275K 0.21% 112
2021
Q1 		$24.8M Sell
79,769
-36
-0% -$12.6K 0.19% 116
2020
Q4 		$20M Sell
79,805
-993
-1% -$243K 0.15% 125
2020
Q3 		$14.9M Buy
80,798
+5,347
+7% +$1.06M 0.14% 118
2020
Q2 		$18.9M Buy
75,451
+10,689
+17% +$2.34M 0.19% 103
2020
Q1 		$11.7M Hold
64,762
– – 0.15% 114
2019
Q4 		$27M Buy
64,762
+27,052
+72% +$8.5M 0.24% 98
2019
Q3 		$9.49M Sell
37,710
-1,139
-3% -$371K 0.09% 159
2019
Q2 		$15.4M Buy
38,849
+10,516
+37% +$4.23M 0.15% 134
2019
Q1 		$15.3M Buy
+28,333
New +$15M 0.14% 132

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

ArrowMark Colorado Holdings's DTIL Position: Q1 2026 in Review

ArrowMark Colorado Holdings opened a new position in Precision BioSciences (DTIL) in Q1 2026: 179,140 shares worth $985K. The stake represents 0.03% of the portfolio and ranks #247 among its holdings. This is a return to the name: ArrowMark Colorado Holdings previously reported a position in DTIL as recently as Q4 2023.

ArrowMark Colorado Holdings first reported a position in DTIL in Q1 2019 and has held it in 21 quarters since. The position peaked at $27.6M in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • ArrowMark Colorado Holdings held 179,140 shares of Precision BioSciences worth $985K as of Q1 2026.
  • Precision BioSciences was a new ArrowMark Colorado Holdings position in Q1 2026.
  • Precision BioSciences made up 0.03% of ArrowMark Colorado Holdings's portfolio in Q1 2026, its #247 holding.
  • ArrowMark Colorado Holdings first reported a position in Precision BioSciences in Q1 2019 and has held it in 21 quarters since.
  • ArrowMark Colorado Holdings's Precision BioSciences position peaked at $27.6M in Q2 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.